Viewing StudyNCT00006010



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006010
Status: COMPLETED
Last Update Posted: 2016-12-07
First Post: 2000-07-05

Brief Title: Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Conditions & Keywords Data

Conditions:
Name
Liver Cancer
Keywords:
Name View
localized unresectable adult primary liver cancer View
advanced adult primary liver cancer View
recurrent adult primary liver cancer View
adult primary hepatocellular carcinoma View